ML:EURONEXT PARISCie Generale des Etablissements Michelin SA Analysis
Data as of 2026-05-25 - not real-time
$133.39
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Mueller Industries is generating strong top‑line momentum with a 19% revenue growth rate and an impressive 28% return on equity, while maintaining a solid cash position of $1.4 bn against minimal debt. Valuation metrics indicate the stock trades at a 17.5× PE, well below the industry average of 29.7×, and the discounted cash‑flow model suggests a fair value of $141.8, implying roughly 12% upside from the current $133.4 price. The dividend yield of 1.05% is modest but the payout ratio of just 14% points to a sustainable income stream. Technical indicators show the price sitting above the 50‑day and 200‑day SMAs, supporting a bullish trend, yet it remains below the 20‑day SMA and the MACD histogram is negative, signaling short‑term caution. Volatility is elevated at 41% over the past 30 days and a beta of 1.14 suggests the stock moves slightly more than the market. The current support at $130.2 and resistance at $141.5 frame the near‑term trading range, while the “Extreme Greed” market sentiment adds a layer of optimism. Overall, the combination of robust fundamentals, undervalued pricing relative to peers, and a sustainable dividend makes the stock attractive for medium‑ to long‑term investors, though the near‑term technical mixed signals advise a measured approach.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near support at $130.2
- Bullish long‑term SMA alignment but bearish MACD histogram
- High 30‑day volatility
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued PE vs industry and DCF upside of ~12%
- Strong revenue growth and 28% ROE
- Sustainable dividend with low payout ratio
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Durable cash generation and low debt levels
- Consistent profitability and high operating margins
- Favorable valuation relative to peers and growth prospects
Key Metrics & Analysis
Financial Health
Revenue Growth19.30%
Profit Margin19.37%
P/E Ratio17.5
ROE28.30%
ROA17.04%
Debt/Equity0.68
P/B Ratio4.4
Op. Cash Flow$721.6M
Free Cash Flow$498.6M
Industry P/E29.7
Technical Analysis
TrendBullish
RSI51.5
Support$130.22
Resistance$141.51
MA 20$136.10
MA 50$124.61
MA 200$113.26
MACDBearish
VolumeStable
Fear & Greed Index91.61
Valuation
Fair Value$141.84
Target Price$149.50
Upside/Downside12.08%
GradeUndervalued
TypeGrowth
Dividend Yield1.05%
Risk Assessment
Beta1.14
Volatility41.79%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.